AMD Initiative for Prevention and Cure - Cleveland Clinic
Patients Professionals About AMD-IPAC Contact Us
Text Size
Increase Text Size
Decrease Text Size
  Commercial Partners & Healthcare Professionals Interested in Joining the AMD Initiative

Intellectual Property

  • Risk markers for age related macular degeneration

  • TIMP3 as a therapeutic for AMD

  • Compositions and methods for macular degeneration

  • VG5Q, a novel target for angiogenesis-mediated disease

  • Animal models of immune-mediated retinal degeneration

© Cleveland Clinic 2006 Site Map | Cleveland Clinic Home | Cole Eye Institute Home
Home | Patients | Professionals | About AMD-IPAC | Contact Us

Ohio's Third Frontier ProjectThe AMD Initiative for Prevention & Cure is supported by
a grant from the state of Ohio's Third Frontier Project.

 Cole Eye Institute CCF Innovations